Metabolic imaging by positron emission tomography in oncology

Annals of Medicine

Volumn 29, Issue 4, 1997, Pages 271-274

  Leskinen, Sirkku ^a   Lapela, Maria ^a   Lindholm, Paula ^a   Minn, Heikki ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cancer; Positron emission tomography; 11C methionine; 18F fluorodeoxyglucose

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18; METHIONINE; TRACER;

CANCER; CANCER RECURRENCE; MEASUREMENT; METABOLISM; MINIMAL RESIDUAL DISEASE; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

EID: 0030874538     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708999347     Document Type: Review

References (23)

1. Laniki LM. Positron emission tomography in oncology. Cancer 1996; 78: 2039-42.
2. Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras and src oncogenes. Science 1987; 235: 1492-5.
3. Weber G. Enzymology of cancer cells. N Engl J Med 1977; 296: 541-51.
4. Hoffman RM. Altered methionine metabolism and trans-methylation in cancer. Anticancer Res 1985; 5: 1-30.
5. 18F]fluorodeoxyglucose in brain tumours. A powerful diagnostic and prognostic tool. Invest Radiol 1987; 22: 360-71.
6. 11C-methionine and positron emission tomography. Am J Neuroradiol 1985; 6: 505-14
7. 11C]L-methionine uptake in gliomas. Neurosurgery 1989; 25: 720-8.
8. Ogawa T, Shishido F, Kanno I, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993; 186: 45-53.
9. 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radiol 1987; 28: 673-81.
10. 18F]fluorodeoxyglucose. J Neurosurg 1995; 82: 445-52.
11. Pardo FS, Aronen HJ, Kennedy D, et al. Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. Int J Radiat Oncol Biol Phys 1994; 30: 663-9.
12. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-7.
13. Knopp MV, Bischoff H, Ostertag H, et al. Clinical applications of FDG PET for staging of bronchogenic carcinoma. J Nucl Med 1993; 34: 21P (Abstr).
14. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186: 27-35.
15. Braams JW, Pruim J, Freling JMF, et al. N. Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995; 36: 211-6.
16. Rigo P, Paulus P, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18-fluorodeoxyglucose. Eur J Nucl Med 1996; 23: 1641-74.
17. 18F]fluorodeoxyglucose. The members of the PET-Lung Tumor Study Group. Ann Thorac Surg 1994; 58: 698-703.
18. Lowe VJ, Hoffman JM, DeLong DM, Patz EF Jr, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35: 1771-6.
19. 18F]fluoro-2-deoxy-D-glucose. Radiology 1995; 197: 205-11.
20. Lapela M, Leskinen S, Minn H, et al. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 1995; 86: 3522-7.
21. Shields AF, Lim K, Grierson J, Link J, Krohn KA. Utilization of labeled thymidine in DNA synthesis: studies for PET. J Nucl Med 1987; 28: 1435-40.
22. Mintun MA, Welch MJ, Siegel BA, et al. PET imaging of estrogen receptors. Radiology 1988; 169: 45-8.
23. Minn H, Nuutila P, Lindholm P, et al. In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma. Cancer 1994; 1490-8.